01/08/2026
𝔽𝕊𝔾𝕊 𝕒𝕟𝕕 𝕥𝕙𝕖 ℝ𝕦𝕝𝕖 𝕠𝕗 4️⃣ !
Remember that ..
📌 ꜰꜱɢꜱ ɪꜱ ᴄᴀᴜꜱɪɴɢ 4️⃣0️⃣ % ᴏꜰ ░N░e░p░h░r░o░t░i░c░ ░s░y░n░d░r░o░m░e░ ɪɴ ᴀᴅᴜʟᴛꜱ ( 20% ɪɴ ᴘᴇᴅɪᴀᴛʀɪᴄꜱ..
📌 ᴄᴀᴜꜱɪɴɢ ░ᴇ░ꜱ░ᴋ░ᴅ░
ɪɴ 4️⃣0️⃣ % ᴏꜰ ᴄᴀꜱᴇꜱ ( 40-60%)..
📌 ɪɴᴄɪᴅᴇɴᴄᴇ ᴏꜰ ░ᴘ░ᴏ░ꜱ░ᴛ░ ░ᴛ░x░ ░ʀ░ᴇ░ᴄ░ᴜ░ʀ░ʀ░ᴇ░ɴ░ᴄ░ᴇ░ ɪꜱ 4️⃣0️⃣ % ( 70-80% ɪɴ 2ɴᴅ ᴛʀᴀɴꜱᴘʟᴀɴᴛ, ɪꜰ ᴛʜᴇ 1ꜱᴛ ᴡᴀꜱ ʟᴏꜱᴛ ᴅᴜᴇ ᴛᴏ ᴅɪꜱᴇᴀꜱᴇ ʀᴇᴄᴜʀʀᴇɴᴄᴇ)..
📌 𝘾𝙖𝙪𝙨𝙞𝙣𝙜 𝙋𝙤𝙨𝙩 𝙏𝙭 𝙍𝙚𝙘𝙪𝙧𝙧𝙚𝙣𝙘𝙚 𝙡𝙚𝙖𝙙𝙞 𝙜 𝙩𝙤 𝙂𝙧𝙖𝙛𝙩 𝙇𝙤𝙨𝙨 𝙞𝙣 4️⃣0️⃣% ( 40-50% ) ..
📌 4️⃣ ░ʙ░ɪ░ᴏ░ᴍ░ᴀ░ʀ░ᴋ░ᴇ░ʀ░ꜱ░ ʟɪɴᴋᴇᴅ ᴛᴏ ᴅɪꜱᴇᴀꜱᴇ ʀᴇᴄᴜʀʀᴇɴᴄᴇ
===> 𝙨𝙪𝙋𝘼𝙍 ( 𝙎𝙤𝙡𝙪𝙗𝙡𝙚 𝙐𝙧𝙤𝙠𝙞𝙣𝙖𝙨𝙚 𝙩𝙮𝙥𝙚 𝙋𝙡𝙖𝙨𝙢𝙞𝙣𝙤𝙜𝙚𝙣 𝘼𝙘𝙩𝙞𝙫𝙖𝙩𝙤𝙧 𝙍𝙚𝙘𝙚𝙥𝙩𝙤𝙧 )
===> 𝙎𝙤𝙡𝙪𝙗𝙡𝙚 𝙏𝙪𝙢𝙤𝙧 𝙉𝙚𝙘𝙧𝙤𝙨𝙞𝙨 𝙁𝙖𝙘𝙩𝙤𝙧 𝙍𝙚𝙘𝙚𝙥𝙩𝙤𝙧 2
===> 𝘼𝙣𝙩𝙞-𝙉𝙚𝙥𝙝𝙧𝙞𝙣 𝘼𝙣𝙩𝙞𝙗𝙤𝙙𝙞𝙚𝙨
===> 𝘼𝙣𝙩𝙞𝘾𝘿40 𝙖𝙣𝙩𝙞𝙗𝙤𝙙𝙞𝙚𝙨
Taiseer Renal Medicine " From A to Zee Nephrology is easy"
NephroTube